Purpose of This Blogger: Informal dialogue aimed at facilitating a constructive exchange of ideas between the decision-makers, stakeholders, and experts across various sectors.
Total Pageviews
Friday, November 7, 2025
Petronet LNG Stock Study and Analysis, Upcoming Dividend, Upcoming Result,
FINOLEX CABLES-Stock Analysis and Study
⚠️ Disclaimer
This study is intended only for educational and analytical purposes. It reflects personal research, interpretation, and historical trend analysis. It is not investment advice. Investors must consult certified financial advisors and consider individual financial goals and risk profiles before making investment decisions.
Dabur - Stock Study and Analysis, Upcoming Dividend, Upcoming Result,
ONGC- Stock Study and Analysis -Upcoming Dividend - Upcoming Result
ONGC Q2-2026 Result date : 10 Nov 2025
ONGC Q2-2026 (July -Sep)
Result Tentative date ~11 November 2025 (Reference Last Year)
Upcoming Dividend ~ Tentative 6.00/-Per Share (Reference Last Year Dividend 6.00/-Per Share Paid on 19November 2024)
📊 Stock Analysis & Study: ONGC
Study Date: 18 September 2025
Legend:
P = Poor 👎🏻 | G = Good 🌸 | D = Dividend | B = Buy | S = Sell | HD = Hold 😅 | HH = High 👍🏻 | L = Low 👎🏻 | M = Mean
🏢 Company Performance & Dividend
Q1 FY25 Results (announced 8 August 2025):
-
Sales: -3% YoY → Poor 👎🏻
-
EBITDA: +18% YoY → Good 🌸
-
Net Profit: -2% YoY → Poor 👎🏻
-
EPS: -2% YoY → Poor 👎🏻
Dividend Policy:
-
ONGC pays dividends three times a year (Aug–Nov–Feb), totaling approximately ₹12 per share annually.
-
Recent payout: 🌸 ₹1.25 per share (already paid in September 2025).
-
Upcoming dividends:
-
November: X/- per share
-
February: X/- per share
-
-
Record Date & Payout Date: To be announced.
💹 Current Market Snapshot
-
Current Price: ₹237 (Below BV = ₹273 👍)
-
52W H/L: ₹345 / ₹205
-
P/E: 8.27 👎 (Sector P/E: 8.84)
-
ROCE: 12% (Low 👎)
-
ROE: 10.6% (Low 👎)
-
Book Value: ₹273 🌸
-
Face Value: ₹5
-
Beta: 1.06 (High volatility 👎)
Price Forecast (H/M/L): ₹340 / ₹273 / ₹205
📈 Seasonality Trend (17-Year Historical Performance)
-
Jan: 8/16 (+2.95%) → Ok
-
Feb: 8/17 (-1.54%) → Poor 👎🏻 (Dividend month)
-
Mar: 8/17 (-0.02%) → Poor 👎🏻
-
Apr: 13/17 (+3.52%) → Very Good 🌸🌸🌸 (Sell & book profits)
-
May: 8/17 (+2.39%) → Sell
-
June: 10/17 (+0.62%) → Good 🌸 (Sell)
-
July: 7/17 (-1.11%)
-
Aug: 8/17 (-0.58%) → Dividend month
-
Sep: 9/17 (+1.53%) → Ok
-
Oct: 8/17 (+0.84%)
-
Nov: 5/17 (-0.73%) → Poor 👎🏻 (Buy opportunity + Dividend)
-
Dec: 9/17 (+1.37%)
📊 Institutional & Financial Indicators
-
Piotroski Score: 4 👎 → Weak financial health
-
FII: 7.09% (↓ from 7.12%)
-
DII: 30.14% (↓ from 30.24%)
-
Promoter Holding: Unchanged
-
Total Institutional Holding: 37.23% (↓ from 37.36%)
🧭 Strategy Outlook
-
Short-term trading opportunities (based on seasonality & dividend trends):
-
Buy in Feb, Sell in Apr
-
Buy in May, Sell in June
-
Buy in July, Sell in Aug
-
Buy in Nov, Sell in Dec
-
👉 If already holding ONGC, best exit window could be in November (post-dividend bounce).
✅ Buy or Not Buy?
-
Current price below book value (positive 🌸)
-
Weak YoY profit/EPS growth 👎🏻
-
Attractive dividend yield (approx. 5%) 🌸
-
High volatility (Beta > 1) 👎🏻
🔎 Interpretation: ONGC appears more suited for dividend-focused investors and short-term seasonal trades rather than long-term compounding, given weak growth metrics.
⚠️ Disclaimer
This report is prepared for educational and analytical purposes only. It reflects personal research, interpretation, and historical trend analysis. This is not investment advice. Please consult a SEBI-registered financial advisor and align with your financial goals and risk profile before making any investment decisions.
Stock Analysis and Study
ONGC
Study on 18.09.2025
P-Poor👎🏻
G- Good 🌸
D-Dividend
B-Buy
S-Sell
HD-Hold 😅
HH-High 👍🏻
L-Low 👎🏻
M- Mean
--------------------------------------
Company Performance & Dividend
Result :June Result ⬇️ % YOY
Sale : (-3%) Poor👎🏻
EBIDT: (+18%)Good 🌸
Net Profit:(-2%) Poor👎🏻
EPS: (-2%) Poor👎🏻
Result : Q1-8 August 2025
-------------------------------------
Paying dividend 3 time in year (August-Nov-Feb =apprx. 12 /- in a year)
Dividend Announce :🌸 1.25/- per Share (already paid in Sep )
Upcoming dividend payout in
Nov: X/-per Share
Feb : X/-Per Share
Record date :
Payout date :
--------------------------------------
Current Market Snapshot
Current Price: 237 (Below BV=273👍)
52W H/L: 345/205
PE: 8.27 (👎)
PE Sector: 8.84
ROCE:12%(Low👎)
ROE: 10.6% (Low👎)
Book Value :273 (Good 🌸)
Face Value:5
Beta: 1.06(Bad👎)
Forcast:H/M/L
340/273/205
-------------------------------------
Seasonality Trend (Last 17 Years Performance)
Seasonality
Positive result in
Jan: 8/16 (Ok)(+2.95%)
Feb: 8/17 (Poor👎🏻) Dividend(-1.54%)
Mar: 8/17 (Poor👎🏻)(-0.02%)
Apr: 13/17 (V.good🌸🌸🌸) (Sell and book Profit)(+3.52%)
May: 8/17 (+2.39%) Sell
June: 10/17 (Good🌸) (+0.62%) Sell
July :7/17 (-1.11%)
Aug: 8/17 (Dividend)(-0.58%)
Sep: 9/17 (Ok)(+1.53%)
Oct: 8/17 (+0.84%)
Nov: 5/17 (Poor👎🏻)(Buy) Dividend (-0.73%)
Dec: 9/17(+1.37%)
–-------------------------------------
Piotroski Score : 4 👎 (Poor) weak Finance
FII: 7.09% (7.12%)⬇️
DII: 30.14% (30.24%)⬇️
Promoter:unchange
Institution Invester : 37.23% (37.36%)⬇️
⬆️⬇️ 🌸👍🏻👎🏻😅current% (old%)
------------------------------------
Strategy Outlook
Shareholding max upto
In current case -Nov (Dividend)
For Max Profit
1.Buy in Feb,---Sell in April,
2. Buy in May,---Sell in June,
3.Buy in July,---Sell in August,
4.Buy in Nov,---Sell in Dec,
Confidence Vote
👉 If you already hold this stock, best exit opportunity may come in Nov .
Buy or Not Buy Decision
⚠️ Disclaimer
This study is intended only for educational and analytical purposes. It reflects personal research, interpretation, and historical trend analysis. It is not investment advice. Investors must consult certified financial advisors and consider individual financial goals and risk profiles before making investment decisions.
Nucleus Software - Stock Analysis and Study - Upcoming Dividend Upcoming Result
Nucleus Soft
Q2-2026 Result : 08 Nov 2025
📊 Stock Study & Analysis
Nucleus Software
Study Date: 20.08.2025
🔹 Company Performance & Dividend
-
Dividend Payout: Once a year in July → ₹12/- per share
-
Latest Dividend Announced: ₹12.50/- per share
-
Record Date: (Not specified)
-
Payout Date: 11.07.2025 (Already Paid)
🔹 Current Market Snapshot
-
CMP: ₹1018
-
Book Value (BV): ₹304 (Low)
-
52W H/L: ₹1574 / ₹724
-
PE Ratio: 16.2 (Low) vs. Sector PE: 27.50
-
ROCE: 22.6% (Good)
-
ROE: 16.8% (Good)
-
Face Value: ₹10
-
Beta: 1.11 (High Risk / Volatile)
-
Piotroski Score: 4 (Weak Financials)
🔹 Institutional Investment Trend
-
FII: Increasing 📈
-
DII: Slight decrease 📉
🔹 Forecast Levels
-
High / Mean / Low: 1350 / 1350 / 1350
🔹 Seasonality Trend (Last 17 Years Performance)
| Month | Positive Return % | Frequency (Times) | Remark |
|---|---|---|---|
| Jan | 50% | 8/17 | Average |
| Feb | 29.41% | 5/17 | ❌ Very Poor (Buy) |
| Mar | 35.29% | 6/17 | ❌ Poor |
| Apr | 94.12% | 16/17 | ✅ Very Good (Best Sell Month) |
| May | 47.06% | 8/17 | Poor |
| June | 47.06% | 8/17 | Poor |
| July | 47.06% | 8/17 | Poor |
| Aug | 47.06% | 8/17 | Poor |
| Sep | 50.00% | 8/17 | Average (Sell) |
| Oct | 37.50% | 6/17 | Buy Opportunity |
| Nov | 37.50% | 6/17 | Buy Opportunity |
| Dec | 37.50% | 6/17 | Buy Opportunity |
🔹 Strategy Outlook
-
Buy Months: Feb – Mar
-
Sell Month: April (ideal profit booking window)
-
Holding Period: Upto April 2026 for maximum profit potential
🔹 Confidence Vote
⚠️ Not recommended to buy at current levels.
👉 If you already hold this stock, best exit opportunity may come in January.
⚠️ Disclaimer
This study is intended only for educational and analytical purposes. It reflects personal research, interpretation, and historical trend analysis. It is not investment advice. Investors must consult certified financial advisors and consider individual financial goals and risk profiles before making investment decisions.
Crompton Greaves- Stock Analysis and Study Upcoming Dividend - Upcoming Result
Crompton Greaves
Study on 07.11.2025
Current Price: 280 (10 time Above Book Value: 48.26)
P-Poor👎🏻
G- Good 🌸
D-Dividend
B-Buy
S-Sell
HD-Hold 😅
HH-High 👍🏻
L-Low 👎🏻
M- Mean
-----------------------------------
Q2-2026 (July-Sep) Result on 6 Nov 2025-
Very poor Result
Result ⬇️ % YOY
Sale : (+1%) Poor👎🏻
EBIDT: (-22%) Poor👎🏻
Net Profit:(-32%) Poor👎🏻
EPS: (-43%) Poor👎🏻
-----------------------------------
Result :Q1 2026 June Result ⬇️ % YOY
Sale : (-7%) Poor👎🏻
EBIDT: (-18%) Poor👎🏻
Net Profit:(-19%) Poor👎🏻
EPS;: (-19%) Poor👎🏻
-----------------------------------
Paying dividend 1 time in year (3/- in July)
Dividend Announce :🌸 3/- per Share (already paid in July )
Record date :
Payout date :
-----------------------------------
Current Price: 285/-
52W H/L: 469/301
PE: 38.90 (Good🌸)
PE Sector: 70.58
ROCE:19% (Good🌸)
ROE: 17.4 (Good🌸)
Book Value :48.26 (Low)
Face Value:2
Beta: 0.71 (Good🌸)
Forcast:H/M/L
470/406/335
-----------------------------------
Seasonality
Positive result in
Jan: 3/9 (Poor,👎) (+2.89%)
Feb:1/9( V.poor👎👎) (-4.31) Buy
Mar:5/9 (Poor 👎) (-1.46%)
Apr:5/9 (Poor 👎)(+1.60)
May: 7/9 (V.good🌸🌸)(+3.50%)
(Sell and book Profit)
June:8/10( V.good🌸🌸)(+2.65%)
(Sell and book Profit)
July: 7/10 (+4.65%)
Aug :8/9 (V.good🌸🌸) (+3.02%) sell
Sep:5/10(Poor👎) (-1.64%) Buy
Oct: 3/9 (Poor👎) (-0.76%) Buy
Nov:7/9 (V.Good🌸🌸)(+0.96%) Sell
Dec:4/9 (Poor👎)(+2.25%)
---------------------------------
Piotroski Score : 7 🌸🌸 (V.Good) Strong Finance
FII: 29.20% (30.34)
DII: 58.93% (57.04%)
Promoter:unchange
Institution Invester : 88.13% (87.38%)
⬆️⬇️ 🌸👍🏻👎🏻😅current% (old%)
-----------------------------------
Shareholding max upto
In current case -Nov
Sell out near result date.
For Max Profit
1. Buy in Feb,---Sell in May-June-July- August,
2. Buy in Sep - Oct Sell in Nov-Dec
Remark: Not seeing improvement till next year May 2026
Stock Analysis / Study
Company: Crompton Greaves
Date: 10.09.2025
Key Valuation Metrics
-
Current Price: ₹319
-
Book Value: ₹48.26 → 10x above book value (Expensive)
-
P/E Ratio: 38.90 🌸 (Sector PE: 70.58 – Relatively Attractive)
-
ROCE: 19% 🌸 (Healthy)
-
ROE: 17.4% 🌸 (Good Return on Equity)
-
Face Value: ₹2
-
Beta: 0.71 🌸 (Low Volatility – Defensive Stock)
-
52W H/L: ₹469 / ₹301
Current Price: ₹319
Book Value: ₹48.26 → 10x above book value (Expensive)
P/E Ratio: 38.90 🌸 (Sector PE: 70.58 – Relatively Attractive)
ROCE: 19% 🌸 (Healthy)
ROE: 17.4% 🌸 (Good Return on Equity)
Face Value: ₹2
Beta: 0.71 🌸 (Low Volatility – Defensive Stock)
52W H/L: ₹469 / ₹301
📊 Forecast Price Range (H/M/L): ₹470 / ₹406 / ₹335
Quarterly Performance (June 2025 – YoY)
-
Sales: ↓ 7% 👎🏻 (Poor)
-
EBITDA: ↓ 18% 👎🏻 (Poor)
-
Net Profit: ↓ 19% 👎🏻 (Poor)
-
EPS: ↓ 19% 👎🏻 (Poor)
Sales: ↓ 7% 👎🏻 (Poor)
EBITDA: ↓ 18% 👎🏻 (Poor)
Net Profit: ↓ 19% 👎🏻 (Poor)
EPS: ↓ 19% 👎🏻 (Poor)
📉 Observation: Weak operational and bottom-line performance.
Dividend Policy
-
Dividend Frequency: Once a year (July)
-
Latest Dividend (July 2025): ₹3 per share 🌸
-
Record Date / Payout Date: [Data not provided]
Dividend Frequency: Once a year (July)
Latest Dividend (July 2025): ₹3 per share 🌸
Record Date / Payout Date: [Data not provided]
Seasonality Analysis (Historical Trends)
-
Jan: 3/9 Positive 👎🏻 (+2.89%)
-
Feb: 1/9 Positive 👎👎 (-4.31%) → Buy Opportunity
-
Mar: 5/9 Positive 👎🏻 (-1.46%)
-
Apr: 5/9 Positive 👎🏻 (+1.60%)
-
May: 7/9 Positive 🌸🌸 (+3.50%) → Sell & Book Profits
-
June: 8/10 Positive 🌸🌸 (+2.65%) → Sell & Book Profits
-
July: 7/10 Positive (+4.65%)
-
Aug: 8/9 Positive 🌸🌸 (+3.02%) → Sell Opportunity
-
Sep: 5/10 Positive 👎🏻 (-1.64%) → Buy Opportunity
-
Oct: 3/9 Positive 👎🏻 (-0.76%) → Buy Opportunity
-
Nov: 7/9 Positive 🌸🌸 (+0.96%) → Sell Opportunity
-
Dec: 4/9 Positive 👎🏻 (+2.25%)
Jan: 3/9 Positive 👎🏻 (+2.89%)
Feb: 1/9 Positive 👎👎 (-4.31%) → Buy Opportunity
Mar: 5/9 Positive 👎🏻 (-1.46%)
Apr: 5/9 Positive 👎🏻 (+1.60%)
May: 7/9 Positive 🌸🌸 (+3.50%) → Sell & Book Profits
June: 8/10 Positive 🌸🌸 (+2.65%) → Sell & Book Profits
July: 7/10 Positive (+4.65%)
Aug: 8/9 Positive 🌸🌸 (+3.02%) → Sell Opportunity
Sep: 5/10 Positive 👎🏻 (-1.64%) → Buy Opportunity
Oct: 3/9 Positive 👎🏻 (-0.76%) → Buy Opportunity
Nov: 7/9 Positive 🌸🌸 (+0.96%) → Sell Opportunity
Dec: 4/9 Positive 👎🏻 (+2.25%)
Financial Strength & Shareholding
-
Piotroski Score: 7 🌸🌸 (Very Good – Strong Financial Position)
-
FII Holding: 29.20% (Previous: 30.34%) ⬇️
-
DII Holding: 58.93% (Previous: 57.04%) ⬆️
-
Promoter Holding: Unchanged
-
Total Institutional Investors: 88.13% (Previous: 87.38%) ⬆️
Piotroski Score: 7 🌸🌸 (Very Good – Strong Financial Position)
FII Holding: 29.20% (Previous: 30.34%) ⬇️
DII Holding: 58.93% (Previous: 57.04%) ⬆️
Promoter Holding: Unchanged
Total Institutional Investors: 88.13% (Previous: 87.38%) ⬆️
Investment Strategy (Seasonality-Based)
For Maximum Profit Potential:
-
Buy in Feb → Sell in May–June–July–Aug
-
Buy in Sep–Oct → Sell in Nov–Dec
Verdict
-
Valuation: Expensive (10x Book Value), but supported by strong ROCE & ROE.
-
Performance: Current quarter results weak 👎🏻.
-
Positives: Strong institutional holding, low beta, good Piotroski score.
-
Negatives: Sales and profit decline, high valuation.
Valuation: Expensive (10x Book Value), but supported by strong ROCE & ROE.
Performance: Current quarter results weak 👎🏻.
Positives: Strong institutional holding, low beta, good Piotroski score.
Negatives: Sales and profit decline, high valuation.
Disclaimer
This document is purely for educational and analytical purposes only. It represents personal study, data interpretation, and thought-provoking observations. It does not constitute investment advice or a recommendation. Investors must make independent decisions after consulting certified financial advisors, taking into account their own objectives and risk appetite.
Stock Analyze /Self Study on 10.09.2025
Crompton Greaves
Current Price: 317 (10 time Above Book Value: 48.26)
P-Poor👎🏻
G- Good 🌸
D-Dividend
B-Buy
S-Sell
HD-Hold 😅
HH-High 👍🏻
L-Low 👎🏻
M- Mean
--------------------------------------
Result :June Result ⬇️ % YOY
Sale : (-7%) Poor👎🏻
EBIDT: (-18%) Poor👎🏻
Net Profit:(-19%) Poor👎🏻
EPS;: (-19%) Poor👎🏻
-------------------------------------
Paying dividend 1 time in year (3/- in July)
Dividend Announce :🌸 3/- per Share (already paid in July )
Record date :
Payout date :
--------------------------------------
Current Price: 319
52W H/L: 469/301
PE: 38.90 (Good🌸)
PE Sector: 70.58
ROCE:19% (Good🌸)
ROE: 17.4 (Good🌸)
Book Value :48.26 (Low)
Face Value:2
Beta: 0.71 (Good🌸)
Forcast:H/M/L
470/406/335
-------------------------------------
Seasonality
Positive result in
Jan: 3/9 (Poor,👎) (+2.89%)
Feb:1/9( V.poor👎👎) (-4.31) Buy
Mar:5/9 (Poor 👎) (-1.46%)
Apr:5/9 (Poor 👎)(+1.60)
May: 7/9 (V.good🌸🌸)(+3.50%)
(Sell and book Profit)
June:8/10( V.good🌸🌸)(+2.65%)
(Sell and book Profit)
July: 7/10 (+4.65%)
Aug :8/9 (V.good🌸🌸) (+3.02%) sell
Sep:5/10(Poor👎) (-1.64%) Buy
Oct: 3/9 (Poor👎) (-0.76%) Buy
Nov:7/9 (V.Good🌸🌸)(+0.96%) Sell
Dec:4/9 (Poor👎)(+2.25%)
–-------------------------------------
Piotroski Score : 7 🌸🌸 (V.Good) Strong Finance
FII: 29.20% (30.34)
DII: 58.93% (57.04%)
Promoter:unchange
Institution Invester : 88.13% (87.38%)
⬆️⬇️ 🌸👍🏻👎🏻😅current% (old%)
------------------------------------
Shareholding max upto
In current case -Nov
For Max Profit
1. Buy in Feb,---Sell in May-June-July-August,
2. Buy in Sep - Oct Sell in Nov-Dec
Disclaimer:
The purpose of this article is only to share interesting charts, data points and thought-provoking opinions. It is NOT a recommendation. If you wish to consider an investment, you are strongly advised to consult your advisor. This article is strictly for educative purposes only.